Rapid Micro Biosystems, Inc.
RPID
$3.65
-$0.02-0.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.41% | 29.68% | 23.74% | 32.31% | 11.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.41% | 29.68% | 23.74% | 32.31% | 11.44% |
| Cost of Revenue | -4.67% | 11.18% | -10.21% | -1.26% | 4.53% |
| Gross Profit | 126.53% | 670.35% | 138.14% | 90.01% | 14.92% |
| SG&A Expenses | -5.24% | -10.23% | -6.70% | -4.87% | -10.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.12% | -0.42% | -4.62% | -0.30% | -0.12% |
| Operating Income | 18.30% | 16.07% | 16.68% | 11.13% | 4.03% |
| Income Before Tax | 15.49% | 13.34% | 15.48% | 10.33% | 4.04% |
| Income Tax Expenses | 133.33% | -212.50% | 30.00% | 150.00% | -57.14% |
| Earnings from Continuing Operations | 15.46% | 13.48% | 15.45% | 10.26% | 4.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.46% | 13.48% | 15.45% | 10.26% | 4.07% |
| EBIT | 18.30% | 16.07% | 16.68% | 11.13% | 4.03% |
| EBITDA | 19.55% | 16.97% | 17.34% | 12.74% | 4.55% |
| EPS Basic | 16.91% | 14.75% | 16.60% | 11.40% | 5.02% |
| Normalized Basic EPS | 16.94% | 14.53% | 16.59% | 11.50% | 4.99% |
| EPS Diluted | 16.91% | 14.75% | 16.60% | 11.40% | 5.02% |
| Normalized Diluted EPS | 16.94% | 14.53% | 16.59% | 11.50% | 4.99% |
| Average Basic Shares Outstanding | 1.73% | 1.46% | 1.37% | 1.29% | 1.01% |
| Average Diluted Shares Outstanding | 1.73% | 1.46% | 1.37% | 1.29% | 1.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |